Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Avon shareholders to vote on parabens

This article was originally published in The Rose Sheet

Executive Summary

Shareholders to vote on resolution requiring direct-seller to conduct study on the feasibility of removing parabens from products at annual meeting May 1. Resolution is sponsored by investment firm Domini Social Investments and advocacy group Breast Cancer Action. In proxy statement filed with Securities and Exchange Commission March 27, Avon advises shareholders to oppose the resolution, noting "parabens are recognized as safe by The World Health Organization and the Cosmetic Ingredient Review Expert Panel. Advocacy group argues parabens are linked to breast cancer. Group is targeting Avon because of the direct-seller's association with efforts to raise money to fight the disease. Avon has at least 82 products containing parabens...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts